Hero background pattern

Meet your next launch strategy partner

Remap Consulting is the pricing and market access launch partner to help you launch with confidence.

How we can support you:
Pricing & Reimbursement Launch Strategy
Joint Clinical Assessment
HTA/Payer Early Dialogue
Payer Value Communication Strategy
Launch Implementation

We can help you

  • Develop and implement a pricing and market access launch strategy for your product
  • Provide pricing and market access launch expertise to global, regional and local teams
  • Prepare, file and co-ordinate country specific HTA / pricing and reimbursement submissions
  • Obtain early payer scientific advice to integrate payer insights into your clinical development program
  • Develop an evidence-based value proposition that resonates with payers

Discover the latest insights

Scotland leads the UK in approving Mounjaro for ob…
Scottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils…
Read more
Securing the optimum launch price for a novel phar…
Looking to enhance your market access capabilities? Remap Consulting are the partner to help you lau…
Read more
World EPA Congress 2024
The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar…
Read more
market access
Is the attractiveness of launch in the UK changing…
This expert article focusses on the new proportionate approach, and the international recognition pr…
Read more
ISPOR Europe 2023
We’re thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We’ll…
Read more
World Orphan Drug Congress Europe 2023 REPORT
We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
NICE’s Proportionate Approach to Technology …
Webinar: Our experts discuss NICE’s proportionate approach to technology appraisals and the implicat…
Read more
ISPOR Europe 2023: Can Just Three PICOs be Feasibl…
This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment…
Read more
ISPOR Europe 2023: How Aware Are Biotech and Pharm…
Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in…
Read more
ISPOR Europe 2023: How Has NICE’s Severity M…
Our study aims to understand how the severity modifier has been implemented so far and its impact on…
Read more

I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.

Director of Market Access
Small pharma payer insights for clinical trials

Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.

Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.